This site is intended for healthcare professionals only
DiabetesontheNet Logo
Share this article

Updated NICE CG71 guideline on familial hypercholesterolaemia

By Pam Brown, GP and Editor-in-Chief of Diabetes & Primary Care


The recent update to the familial hypercholesterolaemia (FH) NICE guideline (CG71) advises that healthcare professionals should suspect FH in people with a total cholesterol level greater than 7.5 mmol/L and/or a personal or family history of premature coronary heart disease (an event before 60 years of age in the index individual or first-degree relative). People with FH who are intolerant of statins should be referred to a specialist for initiation of other therapy.

A new recommendation cross-referring to the Technology Appraisal guidance on alirocumab (TA393) and evolocumab (TA394) has also been added. Nicotinic acid no longer has a UK licence, and therefore it has been removed from the guideline recommendations.

Click here to access the full guideline (external content).

Related content
Free for all UK & Ireland healthcare professionals

Sign up to all DiabetesontheNet journals


By clicking ‘Subscribe’, you are agreeing that are able to email you periodic newsletters. You may unsubscribe from these at any time. Your info is safe with us and we will never sell or trade your details. For information please review our Privacy Policy.

DiabetesontheNet Logo

Are you a healthcare professional? This website is for healthcare professionals only. To continue, please confirm that you are a healthcare professional below.

We use cookies responsibly to ensure that we give you the best experience on our website. If you continue without changing your browser settings, we’ll assume that you are happy to receive all cookies on this website. Read about how we use cookies.